3Stenman UH. Prostate specific antigen, clinical use and stating;an overview. Br J Urol, 1997,79(suppl) 1: 44.
4Herschman JD, Smith DS, Catalona WJ, Effect of ejaculation on serum total and free prostate specific antigen concentration. Uro- logy, 1997,50: 239.
5Ravery V, Boccon Gibod L. Free/total prostate specific antigen ratio hope and controversies. Eur Urol, 1997,31:385.
6Stamey TA. Some comments on progress in the standardization of im munoassays for prostate specific antigen. Br J Urol, 1997,79(Suppl)1:49.
7Stephan C, Lein M, Jung K, et al. The influence of prostate volumne on the ratio of free to total prostate specific antigen in seurm of patients with prostate carcinoma and benign prostate hyperplasis,Cancer, 1997,79: 101.
7MOUL J W, MERSEBURGER A S, SRIVASTAVA S. Molecular markers in prostate cancer: the role in preoperative staging[J]. Clin Prostate Cancer, 2002,1 (1) : 42-50
8IRANI J ,LEVILLAIN P ,GOUJON J M ,et al. Inflammation in bengin prostatic hyperplasia: correlation with prostate specific antigen value [J]. J Urol, 1997,157 (4): 1301-1303
9DOUGLAS T H, MORGAN T O, MCLEAD D G, et al. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostateetomy patients[J]. Cancer, 1997,80:107-114
10Moul JW,Merseburger AS,Srivastava S.Molecular markersin prostate cancer:the role in preoperative staging[J].ClinProstate Cancer,2002,1(1):42-50.
